Nanocarriers as an Emerging Platform for Cancer Therapy

December 1, 2007

Abstract

Nanotechnology has the potential to revolutionize cancer diagnosis and therapy. Advances in protein engineering and materials science have contributed to novel nanoscale targeting approaches that may bring new hope to cancer patients. Several therapeutic nanocarriers have been approved for clinical use. However, to date, there are only a few clinically approved nanocarriers that incorporate molecules to selectively bind and target cancer cells. This review examines some of the approved formulations and discusses the challenges in translating basic research to the clinic. We detail the arsenal of nanocarriers and molecules available for selective tumour targeting, and emphasize the challenges in cancer treatment.

Cited by

This article is cited by 1744 publications

  1. Zhang, T., Li, N., Wang, R., Sun, Y., He, X., Lu, X., Chu, L., & Sun, K. (2023). Enhanced therapeutic efficacy of doxorubicin against multidrug-resistant breast cancer with reduced cardiotoxicity. Drug delivery, 30(1), 2189118. https://doi.org/10.1080/10717544.2023.2189118
  2. Kwantwi L. B. (2023). The dual and multifaceted role of relaxin-2 in cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 10.1007/s12094-023-03146-0. Advance online publication. https://doi.org/10.1007/s12094-023-03146-0
  3. Haq Khan, Z. U., Khan, T. M., Khan, A., Shah, N. S., Muhammad, N., Tahir, K., Iqbal, J., Rahim, A., Khasim, S., Ahmad, I., Shabbir, K., Gul, N. S., & Wu, J. (2023). Brief review: Applications of nanocomposite in electrochemical sensor and drugs delivery. Frontiers in chemistry, 11, 1152217. https://doi.org/10.3389/fchem.2023.1152217
  4. Wang, Q., Atluri, K., Tiwari, A. K., & Babu, R. J. (2023). Exploring the Application of Micellar Drug Delivery Systems in Cancer Nanomedicine. Pharmaceuticals (Basel, Switzerland), 16(3), 433. https://doi.org/10.3390/ph16030433
  5. Schröder, M., Petrova, M., Dobrikov, G. M., Grancharov, G., Momekova, D., Petrov, P. D., & Ugrinova, I. (2023). Micellar Form of a Ferrocene-Containing Camphor Sulfonamide with Improved Aqueous Solubility and Tumor Curing Potential. Pharmaceutics, 15(3), 791. https://doi.org/10.3390/pharmaceutics15030791